Format

Send to

Choose Destination
Antimicrob Agents Chemother. 2013 Aug;57(8):4046-9. doi: 10.1128/AAC.00663-13. Epub 2013 May 28.

Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients.

Author information

1
Department of Pediatrics, Kawasaki Medical School, Okayama, Japan.

Abstract

We conducted nationwide surveillance to investigate regional differences in macrolide-resistant (MR) Mycoplasma pneumoniae strains in Japan. The prevalence of MR M. pneumoniae in pediatric patients gradually increased between 2008 and 2012. Although regional differences were observed, high levels of MR genes were detected in all seven surveillance areas throughout Japan and ranged in prevalence from 50% to 93%. These regional differences were closely related to the previous administration of macrolides.

PMID:
23716043
PMCID:
PMC3719750
DOI:
10.1128/AAC.00663-13
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center